人胎盘药物针灸治疗慢性颞下颌关节紊乱的疗效、安全性与经济学评估:多中心随机对照试验方案
本研究为一项两臂平行、评估者盲法、多中心随机对照试验方案,计划纳入82例慢性颞下颌关节紊乱(TMD)患者,随机分配至人胎盘药物针灸(HPP)组或物理治疗(PT)组各41例。主要结局为基线至第6周颞下颌疼痛视觉模拟评分(VAS)变化,次要结局包括疼痛数字评分、关节活动度、抑郁指数、下颌功能受限量表、患者整体印象变化及生活质量,并评估安全性与成本效果。
要点
- HPP组与PT组各41例,主要终点为第6周VAS疼痛评分较基线变化。
- 次要结局涵盖NRS、关节活动度、K-BDI-II、JFLS、PGIC及生活质量。
- 将基于不良事件与成本效果数据开展安全性和经济学评估。
核心结论
- 本试验旨在评估HPP相比PT治疗慢性TMD的疗效、安全性和经济学价值。
研究设计与样本
- 两臂平行、评估者盲法、多中心随机对照试验,计划纳入82例慢性TMD患者。
- 从两家韩国韩医学院招募符合RDC/TMD轴I组I诊断标准的患者,随机分为HPP组和PT组各41例。
- 治疗共10轮,基线后第6、9、13、25周进行四次随访,主要终点为第6周。
关键数值与推荐
- 主要结局为基线至第6周颞下颌疼痛VAS评分差值。
- 次要结局包括颞下颌疼痛与不适NRS评分、颞下颌关节活动度、K-BDI-II、JFLS、PGIC评分及生活质量。
- 利用两组不良事件和成本效果数据进行安全性评估与成本效果分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Temporomandibular disorder (TMD) is a condition encompassing clinical symptoms of the temporomandibular joint, masseter muscle, and surrounding structures. Hominis placental pharmacopuncture (HPP), consisting of human placental extract, has been reported as effective for treating chronic musculoskeletal disorders, but a lack of well-designed randomised controlled trial s (RCTs) mean there is insufficient evidence to prove the efficacy of HPP. METHODS: This study is a two-arm parallel, assessor-blinded, multi-centre, randomised controlled trial. We will enrol 82 chronic TMD patients from rwo Korean Medicine hospitals in Axis 1, Group I according to RDC/TMD diagnostic criteria, and randomly allocate 41 patients each to an HPP group and a physical therapy (PT) group. Treatment will be administered in 10 rounds, after which there will be four follow-up visits 6, 9, 13, and 25 weeks from baseline. The primary end point is 6 weeks after baseline, and the primary outcome is the difference in Visual Analogue Scale (VAS) score for temporomandibular pain between baseline and week 6. Secondary outcomes will be Numeric Rating Scale (NRS) scores for temporomandibular pain and discomfort, temporomandibular joint range of motion, the Korean version of Beck's Depression Index-II (K-BDI-II), Jaw Functional Limitation Scale (JFLS), Patient Global Impression of Change (PGIC) scores, and quality of life. Using data on adverse events and cost-effectiveness in the two groups, we will perform a safety assessment and a cost-effectiveness analysis (economic assessment). DISCUSSION: This study will assess the efficacy and safety of HPP for chronic TMD compared with PT. This RCT will provide evidence for the efficacy, safety, and economics of HPP. TRIAL REGISTRATION: clinicaTrials.gov (NCT04087005) / Clinical Research Information Service (CRIS) (KCT0004437) / IRB (JASENG 2017-09-002-002, KHNMCOH 2019-08-002) / Ministry of Food and Drug Safety (No. 31886).
引用
- Kim J, Park KS, Lee YJ, et al. Efficacy, safety, and economic assessment of hominis placental pharmacopuncture for chronic temporomandibular disorder: a protocol for a multicentre randomised controlled trial. Trials. 2020. PMID: 32539850. doi:10.1186/s13063-020-04442-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。